Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Daria Hazuda"'
Autor:
Daniel M. Gorman, Ming-Tain Lai, Carolyn McHale, Meiqing Lu, Don Graham, Julie Strizki, Yanyan Zheng, Shirley Ma, Soha Moltagh, Marc Bailly, SuChun Hseih, Glareh Azadi, Yaoli Song, Fernando Ugarte, Romina Riener, Wendy Blumenschein, Daria Hazuda, Jeffery Nordstrom, Bonnie Howell
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss , Pp 22- (2019)
Externí odkaz:
https://doaj.org/article/f2198540a84f48a28c4ad2e3cd169728
Autor:
Julie Strizki, Nicholas Murgolo, John Gaspar, John Howe, Beth Hutchins, Hiroshi Mohri, David D Ho, Daria Hazuda, Jay Grobler
Publikováno v:
Open Forum Infectious Diseases. 9
Background Molnupiravir is an orally available prodrug of the antiviral nucleoside analog N-Hydroxycytidine (NHC). In preclinical studies NHC has shown broad-spectrum antiviral activity against multiple RNA viruses including SARS-CoV-2. Incorporation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::178ecb42537a8d42f0e6af093002695a
https://doi.org/10.1093/ofid/ofac492.231
https://doi.org/10.1093/ofid/ofac492.231
Autor:
Martine Robberechts, Evan J. Friedman, Dirk Schürmann, Deanne Jackson Rudd, Inge De Lepeleire, Sabrina Fox-Bosetti, Sandra Zhang, Andreas Huser, Daria Hazuda, Marian Iwamoto, JayA Grobler
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss , Pp 4- (2016)
Externí odkaz:
https://doaj.org/article/60ce5e9153db433f920ef25e975011ea
Autor:
Khader Ghneim, Ashish Arunkumar Sharma, Susan Pereira Ribeiro, Slim Fourati, Jeffery Ahlers, Ali Filali-Mouhim, Deanna Kulpa, Xuan Xu, Jessica Brehm, Aarthi Talla, Benigno Rodriguez, Carey Shive, Razvan Cristescu, Andrey Loboda, Robert Balderas, I-ming Wang, Peter Hunt, Daniel Lamarre, Daniel Douek, Daria Hazuda, Michael Lederman, Steven G. Deeks, Rafick-Pierre Sekaly
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c45d665261ea5e4f7c82e64a7353a625
https://doi.org/10.2139/ssrn.4069031
https://doi.org/10.2139/ssrn.4069031
Autor:
Noah Bissonnette, Keun Ah Ryu, Tamara Reyes-Robles, Sharon Wilhelm, Erik Hett, Lee Roberts, Daria Hazuda, Jared Willis, Rob Oslund, Niyi Fadeyi
Despite the growing utilization of visible light photochemistry in both chemistry and biology, a general low-heat photoreactor for use across these different disciplines does not exist. Herein, we describe the design and utilization of a standardized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603c20dd609f941e4334eb97bacb2323
https://doi.org/10.26434/chemrxiv.12552254
https://doi.org/10.26434/chemrxiv.12552254
Autor:
Kristine E Yoder, Amy Espeseth, Xiao-hong Wang, Qingming Fang, Maria Teresa Russo, R Stephen Lloyd, Daria Hazuda, Robert W Sobol, Richard Fishel
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e17862 (2011)
An siRNA screen has identified several proteins throughout the base excision repair (BER) pathway of oxidative DNA damage as important for efficient HIV infection. The proteins identified included early repair factors such as the base damage recognit
Externí odkaz:
https://doaj.org/article/f40eb13761b0465fbe76680f51d1f8b3
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e17612 (2011)
Host DNA repair enzymes have long been assumed to play a role in HIV replication, and many different DNA repair factors have been associated with HIV. In order to identify DNA repair pathways required for HIV infection, we conducted a targeted siRNA
Externí odkaz:
https://doaj.org/article/bb2d4ee2e2cd43dbb71b02ed71331f6a
Autor:
Ismail Kola, Daria Hazuda
Publikováno v:
Current Opinion in Biotechnology. 16:644-646
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c2df6159ba511b7309f6e45652d8216
https://doi.org/10.1016/j.copbio.2005.10.014
https://doi.org/10.1016/j.copbio.2005.10.014
Publikováno v:
Current opinion in chemical biology. 17(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85ce88b1460f09737386e30ee28b9458
https://pubmed.ncbi.nlm.nih.gov/23683350
https://pubmed.ncbi.nlm.nih.gov/23683350
Autor:
Eron, Joseph J., Rockstroh, Jurgen K., Jacques, Reynes, Jaime Andrade Villanueva, Jose Valdez Ramalho Madruga, Linda Gail Bekker, Benjamin, Young, Christine, Katlama, Jose Maria Gatell Artigas, Arribas, Jose R., Mark, Nelson, Havilland, Campbell, Jing, Zhao, Rodgers, Anthony J., Rizk, Matthew L., Larissa, Wenning, Miller, Michael D., Daria, Hazuda, Dinubile, Mark J., Randi, Leavitt, Robin, Isaacs, Robertson, Michael N., Peter, Sklar, Bach Yen Nguyen, Mezzaroma, Ivano, Italy, Rome
Publikováno v:
Eron, J J, Rockstroh, J K, Reynes, J, Andrade-Villanueva, J, Ramalho-Madruga, J V, Bekker, L G, Young, B, Katlama, C, Gatell-Artigas, J M, Arribas, J R, Nelson, M, Campbell, H, Zhao, J, Rodgers, A J, Rizk, M L, Wenning, L, Miller, M D, Hazuda, D, DiNubile, M J, Leavitt, R, Isaacs, R, Robertson, M N, Sklar, P, Nguyen, B Y, Laursen, A L & QDMRK Investigators 2011, ' Raltegravir once daily or twice daily in previously untreated patients with HIV-1 : A randomised, active-controlled, phase 3 non-inferiority trial ', The Lancet Infectious Diseases, vol. 11, no. 12, pp. 907-915 . https://doi.org/10.1016/S1473-3099(11)70196-7
Lancet infectious diseases, 11(12), 907-915. Lancet Publishing Group
Lancet infectious diseases, 11(12), 907-915. Lancet Publishing Group
Background: Twice-daily raltegravir with once-daily tenofovir-emtricitabine is an effective initial antiretroviral regimen for patients with HIV-1. On the basis of pharmacokinetic data suggesting efficacy of once-daily raltegravir and because adheren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d45694a6e3952a234f3eea634809c3
https://pure.au.dk/portal/da/publications/raltegravir-once-daily-or-twice-daily-in-previously-untreated-patients-with-hiv1(6e27858b-c904-4f40-96e7-c40413c95477).html
https://pure.au.dk/portal/da/publications/raltegravir-once-daily-or-twice-daily-in-previously-untreated-patients-with-hiv1(6e27858b-c904-4f40-96e7-c40413c95477).html